Ludwig-Maximilians-Universität München
Overview
Ludwig-Maximilians-Universität München is a leading public research university in Munich, Germany, that supports entrepreneurship and innovation through its internal knowledge transfer programs, incubators, and research funding initiatives.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| baseclick | Mar 2008 | Seed | Co-investor |
| VeonGen Therapeutics | Nov 2019 | Series A | Co-investor |
| Limedix GmbH | - | Grant | Co-investor |
| GovRadar | Jun 2021 | Grant | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Ludwig-Maximilians-Universität München based?
Ludwig-Maximilians-Universität München is headquartered in Munich, Germany.
When was Ludwig-Maximilians-Universität München founded?
Ludwig-Maximilians-Universität München was founded in 1472.
How many portfolio companies does Ludwig-Maximilians-Universität München have?
Ludwig-Maximilians-Universität München has 4 portfolio companies in Caplight's dataset.
What are some companies in Ludwig-Maximilians-Universität München's portfolio?
Portfolio companies visible on Caplight include baseclick, VeonGen Therapeutics, Limedix GmbH, GovRadar.
What was Ludwig-Maximilians-Universität München's most recent investment shown here?
Ludwig-Maximilians-Universität München's most recent investment in this portfolio sample was in GovRadar in 2021.
What sectors does Ludwig-Maximilians-Universität München focus on?
Ludwig-Maximilians-Universität München focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software.
What company stages does Ludwig-Maximilians-Universität München focus on?
Ludwig-Maximilians-Universität München typically invests at the Early stage.